Samsung Bioepis Biosimilars Report Slams ‘Stagnant’ US Adalimumab Uptake

Figures From Q4 Reveal Humira Rivals Have Captured Just 2% Of The Market

 
• By Dave Wallace
  
Pie Chart Showing 2% Share, Infographic
Humira biosimilars have so far captured just 2% of the US market • Source: Shutterstock

More from Biosimilars

More from Products